Search Results - "Ijaz, Awais"

Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma by Sagar, Fnu, Malik, Saad Ullah, Soontornprueksa, Supranee, Ijaz, Awais, Usman, Muhammad, Khan, Ali Younas, Tenneti, Pavan, Fraz, Mohammad A, Anwer, Faiz

“…Lenalidomide is commonly used as induction or maintenance therapy in multiple myeloma. We report a case of 71-year-old female presenting with tardive…”
Get full text

Reasons of TB Treatment Non Compliance by Ijaz Awais, Khawaja, Rasheed, M. Arslan, Ejaz, Zoha, Jamshaid, Taj, ., Saim, Latif, Ahmad

“…Objective: To assess the prevalence and reasons of non compliance to treatment of tuberculosis among the patients of Sharif medical city Hospital Lahore…”
Get full text

Advancements in Treatment for Newly Diagnosed Frail and Elderly Myeloma Patients: A Systematic Review by Abdullah, Syed Maaz, Syed, Tariq Iqtidar Sadiq, Faisal, Muhammad Salman, Ijaz, Awais, Batool, Syeda Sabeeka, Ahmad, Muhaddis Ejaz, Yousaf, Muhammad Abdullah, Rehman, Saif Ur, Yusufi, Maaz Ahmed, Kotapati, Sravanthi, Khan, Maimoona, Waheed, Asma, Zaidi, Khadija Zia, Abdullah, Sikander, Anwer, Faiz

“…Introduction: About 60% newly diagnosed multiple myeloma (NDMM) cases are above age of 60 years. The paucity of studies exclusively targeting management of…”
Get full text

Infections Associated with CAR T Therapy for Treatment of Hematological Malignancies by Syed, Tariq Iqtidar Sadiq, Abdullah, Syed Maaz, Rehan, Tayyab, Ahmad, Muhaddis Ejaz, Batool, Syeda Sabeeka, Yousaf, Muhammad Abdullah, Yusufi, Maaz Ahmed, Rehman, Saif Ur, Kotapati, Sravanthi, Khan, Maimoona, Waheed, Asma, Ijaz, Zainab, Ijaz, Awais, Anwer, Faiz

“…Introduction: Chimeric antigen receptor t cells (CAR T) therapy is an innovative adoptive immunotherapy being used for the treatment of CD19+ive B cell…”
Get full text

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials by Samuel, Sharoon, Tariq, Muhammad Junaid, Usman, Muhammad, Khalid, Amna, Fraz, Muhammad Asad, Ijaz, Awais, Jamil, Faiza, Yasir, Muhammad, Ahmad, Malik Qistas, Khalil, Muhammad Jahanzeb, Aslam, Shehroz, Shafqat, Madeeha, Durer, Ceren, Shah, Zunairah, Anwer, Faiz

“…Introduction Recent studies in novel therapies have created opportunities for new treatment regimens to be used in the management of multiple myeloma. Histone…”
Get full text

Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials by Usman, Muhammad, Faridi, Warda, Fraz, Muhammad Asad, Tariq, Muhammad Junaid, Malik, Saad Ullah, Sagar, Fnu, Ijaz, Awais, Hussain, Abid, Ahmad, Malik Qistas, Khalil, Muhammad Jahanzeb, Khalid, Amna, Lakhani, Midhat, Durer, Ceren, Durer, Seren, Anwer, Faiz

“…Introduction: Survival of patients with multiple myeloma (MM) has improved over the last decade, mainly due to advent of newer drugs, three drug based…”
Get full text

The Comparison of Unmanipulated Bone Marrow Versus Peripheral Blood Haploidentical Stem Cell Transplantation in Adult Acute Leukemia: A Systematic Review and Meta-Analysis by Durer, Seren, Durer, Ceren, Jamil, Faiza, Selene, Insija Ilyas, Malik, Mustafa Nadeem, Rafae, Abdul, Abu Zar, Muhammad, Kamal, Ahmad, Ijaz, Awais, Usman, Muhammad, Khan, Ali Younas, Jose, Jemin Aby, Tariq, Muhammad Junaid, Katsanis, Emmanuel, Anwer, Faiz

“…Background: The use of peripheral blood stem cell source (PBSC) continues to grow in the setting of haploidentical hematopoietic stem cell transplantation…”
Get full text

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors by Khan, Ali Younas, Tariq, Muhammad Junaid, Usman, Muhammad, Ijaz, Awais, Rafae, Abdul, Malik, Mustafa Nadeem, Fazeel, Hafiz Muhammad, Nunes Cavalcante Parr, Nadia Carenina, Fraz, Muhammad Asad, Khalil, Muhammad Jahanzeb, Jose, Jemin Aby, Durer, Seren, Durer, Ceren, Anwer, Faiz

“…Introduction Myelofibrosis (MF), a BCR-ABL negative myeloproliferative neoplasm (MPN), has an annual incidence of 1 in 100000 for the primary MF and 0.3-0.7 in…”
Get full text

Diagnostic and Prognostic Role of Fecal Calprotectin As a Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature by Rafae, Abdul, Malik, Mustafa Nadeem, Khan, Ali Younas, Qureshi, Anum, Abu Zar, Muhammad, Durer, Ceren, Durer, Seren, Kamal, Ahmad, Selene, Insija Ilyas, Jose, Jemin Aby, Khalil, Muhammad Jahanzeb, Fazeel, Hafiz Muhammad, Usman, Muhammad, Ijaz, Awais, Anwer, Faiz

“…Introduction: Graft versus host disease (GVHD) is the most significant complication after allogeneic hematopoietic stem cell transplantation (HSCT) and a…”
Get full text

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review by Rahman, Muhammad Aadil, Khan, Ali Younas, Ijaz, Awais, Tariq, Muhammad Junaid, Usman, Muhammad, Khalil, Muhammad Jahanzeb, Fraz, Muhammad Asad, Jamil, Faiza, Rafae, Abdul, Malik, Mustafa Nadeem, Selene, Insija Ilyas, Jose, Jemin Aby, Safdar, Ahmad, McBride, Ali, Anwer, Faiz

“…Introduction Light chain (AL) amyloidosis is a low burden plasma cell disorder, characterized by deposition of misfolded lambda or kappa light chains. Kidney…”
Get full text

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review by Tariq, Muhammad Junaid, Yasir, Muhammad, Khalid, Amna, Amin, Saher Nasir, Samuel, Sharoon, Khalil, Muhammad Jahanzeb, Aslam, Shehroz, Ahmad, Malik Qistas, Fraz, Muhammad Asad, Usman, Muhammad, Ijaz, Awais, Farooqui, Arafat Ali, Durer, Seren, Durer, Ceren, Anwer, Faiz

“…Introduction Selinexor, a SINE (selective inhibitor of nuclear export) compound, inhibits exportin 1 (XPO1) involved in transport of tumor suppressor proteins…”
Get full text

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials by Ahmad, Malik Qistas, Sohail, Chaudhry Saad, Yasir, Muhammad, Tariq, Muhammad Junaid, Akbar, Arshia, Khalil, Muhammad Jahanzeb, Usman, Muhammad, Fraz, Muhammad Asad, Jahngir, Muhammad Umair, Khan, Ali Younas, Ijaz, Awais, Durer, Ceren, Durer, Seren, Anwer, Faiz

“…Background: For most of the elderly or unfit CLL patients, treatment algorithms focus on achievement of clinical response, relief of symptoms and prolongation…”
Get full text

Safety and Efficacy of Venetoclax in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis by Durer, Ceren, Durer, Seren, Ijaz, Awais, Kamal, Ahmad, Abu Zar, Muhammad, Rafae, Abdul, Malik, Mustafa Nadeem, Khan, Ali Younas, Usman, Muhammad, Selene, Insija Ilyas, Tariq, Muhammad Junaid, Fraz, Muhammad Asad, Jose, Jemin Aby, Anwer, Faiz

“…Background: Management of relapsed or refractory multiple myeloma (RRMM) is challenging. Venetoclax (ABT-199) is an oral selective inhibitor of an…”
Get full text

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review by Usman, Muhammad, Tariq, Muhammad Junaid, Ijaz, Awais, Fraz, Muhammad Asad, Khan, Ali Younas, Nunes Cavalcante Parr, Nadia Carenina, Khalil, Muhammad Jahanzeb, Asghar, Arveen, Durer, Seren, Durer, Ceren, Ahmad, Malik Qistas, Sohail, Chaudhry Saad, Malik, Mustafa Nadeem, Anwer, Faiz

“…Introduction Advancement in multiple myeloma (MM) has led to the development of adoptive cell transfer (ACT), an immunotherapeutic modality that utilizes…”
Get full text

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword by Khan, Ali Younas, Ijaz, Awais, Usman, Muhammad, Tariq, Muhammad Junaid, Fraz, Muhammad Asad, Khalil, Muhammad Jahanzeb, Durer, Ceren, Durer, Seren, Sagar, Fnu, Ahmad, Malik Qistas, Sohail, Chaudhry Saad, Shah, Zunairah, Aslam, Shehroz, Anwer, Faiz

“…Introduction: Allogenic stem cell transplantation (allo-SCT) is a potentially curative option for hematological malignancies. Checkpoint inhibitors (CPI) have…”
Get full text

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion by McBride, Ali, Usman, Muhammad, Khalil, Muhammad Jahanzeb, Tariq, Muhammad Junaid, Fraz, Muhammad Asad, Ijaz, Awais, Ahmad, Malik Qistas, Khan, Ali Younas, Samuel, Sharoon, Selene, Insija Ilyas, Camamo, James, Chang, Cara, Jose, Jemin Aby, Anwer, Faiz

“…Introduction: Monoclonal antibody's infusion related reactions (IRRs) include anaphylaxis, anaphylactoid reactions and cytokine release syndrome. These…”
Get full text

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review by Nunes Cavalcante Parr, Nadia Carenina, Tariq, Muhammad Junaid, Usman, Muhammad, Fraz, Muhammad Asad, Khan, Ali Younas, Samuel, Sharoon, Ijaz, Awais, Ahmad, Malik Qistas, Khalil, Muhammad Jahanzeb, Yasir, Muhammad, Amin, Saher Nasir, Safdar, Ahmad, Rafae, Abdul, Anwer, Faiz

“…Introduction: Rationale for anticancer vaccine therapy is based on humoral and/or cellular response against unique tumor antigens (Ag). Peptide vaccines…”
Get full text

Antibodies in Development for Multiple Myeloma: A Systematic Review by Fraz, Muhammad Asad, Tariq, Muhammad Junaid, Usman, Muhammad, Nunes Cavalcante Parr, Nadia Carenina, Ijaz, Awais, Ahmad, Malik Qistas, Yasir, Muhammad, Durer, Seren, Khalil, Muhammad Jahanzeb, Durer, Ceren, Samuel, Sharoon, Amin, Saher Nasir, Safdar, Ahmad, Anwer, Faiz

“…Introduction Immunotherapy using monoclonal antibodies (mAbs) have been gaining significance in the treatment of multiple myeloma (MM). These include naked…”
Get full text

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies for Myelofibrosis by Khan, Ali Younas, Iftikhar, Nimra, Ijaz, Awais, Tariq, Muhammad Junaid, Jamil, Faiza, Akbar, Arshia, Qureshi, Anum, Jose, Jemin Aby, Kamal, Ahmad, Abu Zar, Muhammad, Shafqat, Madeeha, Selene, Insija Ilyas, Aslam, Shehroz, Anwer, Faiz

“…Introduction Drugs that target activating mutations of Janus Kinase 2 (JAK2) have been the backbone of myelofibrosis (MF) management. With recent advancements…”
Get full text

Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review by Durer, Seren, Durer, Ceren, Shafqat, Madeeha, Comba, Isin Yagmur, Malik, Saad, Faridi, Warda, Aslam, Shehroz, Ijaz, Awais, Tariq, Muhammad Junaid, Fraz, Muhammad Asad, Usman, Muhammad, Khan, Ali Y, McBride, Ali, Anwer, Faiz

“…Blinatumomab and donor lymphocyte infusion (DLI) combination is a promising cancer therapy, whereby blinatumomab might achieve an initial reduction in…”
Get full text